These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18413785)

  • 1. Response to letter of Vahle et al.
    Jolette J; Wilker CE; Fox J
    Toxicol Pathol; 2008 Apr; 36(3):520-1. PubMed ID: 18413785
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data.
    Vahle JL; Sato M; Long GG
    Toxicol Pathol; 2007 Dec; 35(7):1045-6. PubMed ID: 18098050
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose.
    Vahle JL; Long GG; Sandusky G; Westmore M; Ma YL; Sato M
    Toxicol Pathol; 2004; 32(4):426-38. PubMed ID: 15204966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats.
    Jolette J; Wilker CE; Smith SY; Doyle N; Hardisty JF; Metcalfe AJ; Marriott TB; Fox J; Wells DS
    Toxicol Pathol; 2006; 34(7):929-40. PubMed ID: 17178693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Bailer AJ
    J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
    Lutz WK
    Toxicol Sci; 2003 Sep; 75(1):223; author reply 223-4. PubMed ID: 12923302
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of k for the poly-k test with application to animal carcinogenicity studies.
    Moon H; Ahn H; Kodell RL; Lee JJ
    Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thresholds in carcinogenicity in ED01 study.
    Rozman KK
    Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioassay design and MTD setting: old methods and new approaches.
    Swenberg JA
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):44-51; discussion 81-6. PubMed ID: 7784635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality in two-year rodent carcinogenicity studies.
    Roth A; Kadyszewski E; Geffray B; Paulissen J; Weaver RJ
    Toxicol Pathol; 2007 Dec; 35(7):1040-3. PubMed ID: 18098048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplastic response of F344 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4'-methylenebis(N,N-dimethyl)-benzenamine, 4,4'-oxydianiline, and 4,4'-methylenedianiline.
    Weisburger EK; Murthy AS; Lilja HS; Lamb JC
    J Natl Cancer Inst; 1984 Jun; 72(6):1457-63. PubMed ID: 6587162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate parameters to be tested in rodent oncogenicity studies.
    Long GG; Symanowski JT
    Toxicol Pathol; 1998; 26(3):319-20. PubMed ID: 9608637
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of in vivo short-term studies on carcinogenic risk assessment.
    Takahashi M
    J Toxicol Sci; 1995 Sep; 20(4):465-7. PubMed ID: 8531243
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response studies with nitrosoheptamethyleneimine and its alpha-deuterium-labeled derivative in F344 rats.
    Lijinsky W; Reuber MD; Davies TS; Riggs CW
    J Natl Cancer Inst; 1982 Nov; 69(5):1127-33. PubMed ID: 6957657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity of butylated hydroxyanisole in F344 rats.
    Ito N; Fukushima S; Hagiwara A; Shibata M; Ogiso T
    J Natl Cancer Inst; 1983 Feb; 70(2):343-52. PubMed ID: 6571941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of carcinogenicity of triethanolamine in F344 rats.
    Maekawa A; Onodera H; Tanigawa H; Furuta K; Kanno J; Matsuoka C; Ogiu T; Hayashi Y
    J Toxicol Environ Health; 1986; 19(3):345-57. PubMed ID: 3772984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.